IHS Chemical Week

Chemical Week Magazine :: Newsbriefs

Companies eyeing Novartis’s animal health business

6:04 AM MST | December 6, 2013

Several companies have emerged as potential buyers of Novartis’s animal health business, press reports say. Novartis CEO, Joe Jimenez, said in November that the company might sell its animal health and OTC businesses if it cannot turn them into global-scale operations. Combined revenues of the two businesses were $3.7 billion in 2012, 19% down on the year before. Novartis is working on a portfolio review with Goldman Sachs, according to Bloomberg. Bayer, which earlier this year acquired Teva Pharmaceutical’s veterinary business, is one of the interested...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa